Latest updates for Rrms

Fresh curated links around RRMS are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • MRI and disability scores better predict RRMS cognitive decline than blood tests
  • New blood test may help track MS disease between relapses
  • Pilot trial tests nerve stimulator to repair myelin damage in RRMS

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

multiplesclerosisnewstoday.com /2 weeks ago

MRI and disability scores better predict RRMS cognitive decline than blood tests

In stable relapsing-remitting multiple sclerosis (RRMS), higher physical disability scores and brain volume loss on MRI are stronger indicators of cognitive impairment than common...

Read source
multiplesclerosisnewstoday.com /1 month ago

New blood test may help track MS disease between relapses

A blood test being developed by Roche to measure a marker of nerve cell damage has received CE mark approval for the detection of neuroinflammation in people with relapsing-remitti...

Read source
multiplesclerosisnewstoday.com /3 weeks ago

Pilot trial tests nerve stimulator to repair myelin damage in RRMS

A pilot clinical trial in the U.S. is enrolling people with relapsing-remitting multiple sclerosis (RRMS) to test Setpoint Medical’s implantable nerve stimulation device, which is...

Read source
multiplesclerosisnewstoday.com /1 month ago

AAN 2026: GA Depot may help stabilize disability in RMS and PPMS

Mapi Pharma’s long-acting formulation of glatiramer acetate, GA Depot, may help stabilize disability scores over time in people with both relapsing forms of multiple sclerosis (MS)...

Read source
multiple-sclerosis-research.org /3 weeks ago

Its Rubbish Throw It in the Bin

This is a phrase I heard someone say when they were describing an MS Drug…I tend to think this when I hear the word PIRA…There is worsening in MS but is it independent of relapse b...

Read source
bioengineer.org /1 week ago

Rethinking Multiple Sclerosis Prognosis with Multiaxial Approach

In a groundbreaking shift in understanding multiple sclerosis (MS), researchers from the Magnetic Resonance Imaging in MS (MAGNIMS) consortium have unveiled a transformative approa...

Read source
multiplesclerosisnewstoday.com /1 month ago

AAN 2026: Ocrevus preserves walking, hand function in early RRMS

First-line treatment with Ocrevus (ocrelizumab) preserved walking abilities and hand function in most people with early relapsing-remitting multiple sclerosis (RRMS) over six years...

Read source
multiple-sclerosis-research.org /1 month ago

MS drugs in the media

News Multiple sclerosis: Could Roche’s bestselling drug Ocrevus be doing more harm than good in women with primary progressive MS? BMJ 2026; 393 doi: https://doi....

Read source
multiplesclerosisnewstoday.com /3 weeks ago

Consortium of Multiple Sclerosis Centers

The post Consortium of Multiple Sclerosis Centers appeared first on Multiple Sclerosis News Today.

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Rrms

bioengineer.org

Recent coverage from public sources
Public source

multiple-sclerosis-research.org

Recent coverage from public sources
Public source

multiplesclerosisnewstoday.com

Recent coverage from public sources
Public source